Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Nibourg, Geert A A ^a   Chamuleau, Robert A F M ^a   van der Hoeven, Tessa V ^a   Maas, Martinus A W ^a   Ruiter, An F C ^a   Lamers, Wouter H ^a   Elferink, Ronald P J Oude ^a   van Gulik, Thomas M ^a   Hoekstra, Ruurdtje ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; APOLIPOPROTEIN A1; CYTOCHROME P450 3A4; DIMETHYL SULFOXIDE; LACTIC ACID;

ACUTE LIVER FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL LIVER; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEPARG CELL; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FAILURE; LIVER CELL; LIVER CELL CULTURE; LIVER FUNCTION; LIVER SUPPORT; NONHUMAN; RAT; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL TIME;

ANIMALS; CELL DIFFERENTIATION; LIVER; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84862491772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038778     Document Type: Article

References (29)

1. Bernal W, Auzinger G, Dhawan A, Wendon J, (2010) Acute liver failure. Lancet 376: 190-201.
2. Sen S, Williams R, Jalan R, (2002) The pathophysiological basis of acute-on-chronic liver failure. Liver 22: 5-13.
3. Liou IW, Larson AM, (2008) Role of liver transplantation in acute liver failure. Semin Liver Dis 28: 201-209.
4. Chan AC, Fan ST, Lo CM, Liu CL, Chan SC, et al. (2009) Liver transplantation for acute-on-chronic liver failure. Hepatol Int 3: 571-581.
5. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, et al. (2006) Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 43: 345-351. 10.1002/hep.21025 [doi].
6. Carpentier B, Gautier A, Legallais C, (2009) Artificial and bioartificial liver devices: present and future. Gut 58: 1690-1702.
7. Flendrig LM, Chamuleau RA, Maas MA, Daalhuisen J, Hasset B, et al. (1999) Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 30: 311-320.
8. Suh KS, Lilja H, Kamohara Y, Eguchi S, Arkadopoulos N, et al. (1999) Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res 85: 243-250.
9. Fruhauf JH, Mertsching H, Giri S, Fruhauf NR, Bader A, (2009) Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver Int 29: 1553-1561.
10. Butterworth RF, (2003) Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int 23: 5-9.
11. Bjerring PN, Hauerberg J, Jorgensen L, Frederiksen HJ, Tofteng F, et al. (2010) Brain hypoxanthine concentration correlates to lactate/pyruvate ratio but not intracranial pressure in patients with acute liver failure. J Hepatol 53: 1054-1058.
12. Li Y, Dong JB, Wu MP, (2008) Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol 590: 417-422.
13. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
14. Cerec V, Glaise D, Garnier D, Morosan S, Turlin B, et al. (2007) Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45: 957-967.
15. Aninat C, Piton A, Glaise D, Le Charpentier T, Langouet S, et al. (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34: 75-83.
16. Hoekstra R, Nibourg GA, van der Hoeven TV, Ackermans MT, Hakvoort TB, et al. (2011) The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 43: 1483-1489.
17. Flendrig LM, la Soe JW, Jorning GG, Steenbeek A, Karlsen OT, et al. (1997) In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 26: 1379-1392.
18. Poyck PP, Mareels G, Hoekstra R, van Wijk AC, van der Hoeven TV, et al. (2008) Enhanced oxygen availability improves liver-specific functions of the AMC bioartificial liver. Artif Organs 32: 116-126.
19. Nibourg GA, Huisman MT, van der Hoeven TV, van Gulik TM, Chamuleau RA, et al. (2010) Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. Liver Transpl 16: 1075-1085.
20. Poyck PP, Hoekstra R, Chhatta A, ten Bloemendaal L, van Wijk AC, et al. (2007) Time-related analysis of metabolic liver functions, cellular morphology, and gene expression of hepatocytes cultured in the bioartificial liver of the Academic Medical Center in Amsterdam (AMC-BAL). Tissue Eng 13: 1235-1246.
21. Deurholt T, van Til NP, Chhatta AA, ten Bloemendaal L, Schwartlander R, et al. (2009) Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC Biotechnol 9: 89.
22. van de Kerkhove MP, Poyck PP, van Wijk AC, Galavotti D, Hoekstra R, et al. (2005) Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs 28: 617-630.
23. Greuet J, Pichard L, Ourlin JC, Bonfils C, Domergue J, et al. (1997) Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture. Hepatology 25: 1166-1175.
24. Terada M, Nudel U, Fibach E, Rifkind RA, Marks PA, (1978) Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells. Cancer Res 38: 835-840.
25. Levy J, Terada M, Rifkind RA, Marks PA, (1975) Induction of erythroid differentiation by dimethylsulfoxide in cells infected with Friend virus: relationship to the cell cycle. Proc Natl Acad Sci U S A 72: 28-32.
26. Sumida K, Igarashi Y, Toritsuka N, Matsushita T, Abe-Tomizawa K, et al. (2011) Effects of DMSO on gene expression in human and rat hepatocytes. Hum Exp Toxicol 30: 1701-1709.
27. Hart SN, Li Y, Nakamoto K, Subileau EA, Steen D, et al. (2010) A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos 38: 988-994.
28. Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu WS, et al. (1994) Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 220: 59-67.
29. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ, (2010) Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 7: 452-470.